Hongmei  Luo Luo

Dr. Hongmei Luo Luo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Cells
Verified
Journal Article
Open access
PDF file
YLYizhou Liu
Yizhou Liu
XCXiaojian Cao Cao
Xiaojian Cao Cao
QZQiuzhi Zhou
Qiuzhi Zhou
CDChunchu Deng
Chunchu Deng
YYYujie Yang
Yujie Yang
HCHong Chen
Hong Chen
Previous studies have revealed that muscle atrophy emerges as a significant challenge faced by astronauts during prolonged missions in space. A loss in muscle mass results in a weakening of skeletal muscle strength and function, which will not only contribute to a decline in overall physical performance but also elevate the risk of various age-related diseases. Skeletal muscle atrophy in the microgravity environment is thought to be associated with changes in energy metabolism, protein metabolism, calcium ion homeostasis, myostatin levels, and apoptosis. Modulating some pathways could be a promising approach to mitigating muscle atrophy in the microgravity environment. This review serves as a comprehensive summary of research on the impact of microgravity on skeletal muscle, with the aim of providing insights into its pathogenesis and the development of effective treatments.

11 March 2025 in Cells
Verified
Journal Article
Open access
PDF file
YYYujie Yang
Yujie Yang
CDChunchu Deng
Chunchu Deng
FAFATIMA ALDALI
FATIMA ALDALI
YHYunjie Huang
Yunjie Huang
HLHongmei Luo Luo
Hongmei Luo Luo
HCHong Chen
Hong Chen
Small extracellular vesicles (sEVs), including exosomes as a subtype, with a diameter typically less than 200 nm and originating from the endosomal system, are capable of transporting a diverse array of bioactive molecules, including proteins, nucleic acids, and lipids, thereby facilitating intercellular communication and modulating cellular functions. Vascular dementia (VaD) represents a form of cognitive impairment attributed to cerebrovascular disease, characterized by a complex and multifaceted pathophysiological mechanism. Currently, the therapeutic approach to VaD predominantly emphasizes symptom management, as no specific pharmacological treatment exists to cure the condition. Recent investigations have illuminated the significant role of sEVs in the pathogenesis of vascular dementia. This review seeks to provide a comprehensive analysis of the characteristics and functions of sEVs, with a particular focus on their involvement in vascular dementia and its underlying mechanisms. The objective is to advance the understanding of the interplays between sEVs and vascular dementia, thereby offering novel insights for future research and therapeutic strategies.